Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

PFIZER LTD. - 500680 - Audited Financial Results And Audit Report For The Financial Year Ended March 31, 2021

 We submit herewith audited financial results for the financial year ended March 31, 2021, Statement of Assets and Liabilities as on March 31, 2021, Statement of Audited Cash Flows for the year ended March 31, 2021, Declaration with respect to Audit Report with unmodified opinion and the Auditor's Report by Auditors, M/s. Walker Chandiok & Co LLP, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 2.15 p.m. and concluded at 4.00 p.m. Further, please be informed that the Board of Directors of the Company has recommended a normal dividend of Rs. 30/- per equity share of Rs. 10/- each (300%) and a special dividend of Rs. 5/- per equity share of Rs. 10/- each (50%), aggregating to total dividend of Rs. 35/- per equity share of Rs. 10/- each (350%) for the year ended March 31, 2021. The said dividend, if declared at the ensuing Annual General Meeting of the Company shall be paid on or before September 15, 2021.
26-05-2021

World's first man to get Covid-19 vaccine dies of unrelated illness

 UK pensioner William Shakespeare received the Pfizer-BioNTech vaccine
26-05-2021

Pfizer says hasn't authorised anyone to import, distribute vaccine in India

 Pfizer tells Moneycontrol it is supplying vaccines only to national governments. The response comes a day after the Maharashtra government said it received bids from intermediaries that claimed to have tie-ups with Pfizer and other vaccine makers.
26-05-2021
Bigul

Annual report for Pfizer Ltd. for FY-2021
26-05-2021

Will ensure vaccine supply, says Centre as Pfizer, Moderna turn down States

 Govt facilitating vaccine-makers but their order-books mostly full now
24-05-2021

Lost opportunity to vaccinate people in time due to Centre's missteps: Sisodia

 Deputy Chief Minister Manish Sisodia on Monday accused the central government of "mismanaging" the coronavirus vaccination programme, saying it has asked states to float global tenders for jabs without giving approval to vaccines of foreign companies. The Deputy Chief Minister in a letter to Union Health Minister Harsh Vardhan also charged that vaccination for the youth in the country has been "messed" up due to policy "missteps". "In spite of early advantages given by our scientific community and Indian manufacturers, we have squandered away the great opportunity of timely vaccination of our people." "The missed opportunity by the Government of India has resulted in extraordinary loss of lives during the current wave of Covid pandemic," he wrote to Vardhan. In an online briefing, Sisodia said US pharmaceutical giants Pfizer and Moderna have refused to sell coronavirus vaccines directly to the Delhi government and have said that they will only talk to the Centre. "Is this a joke?
24-05-2021

States may hit a roadblock in global sourcing quest

 Companies such as Pfizer, Moderna say they negotiate only with Central governments
23-05-2021

Double vaccine shots effective against COVID-19 variant detected in India: UK health body

 A study by Public Health England found the Pfizer-BioNTech vaccine was 88% effective against the coronavirus variant first found in India
23-05-2021

India, Pfizer seek to resolve dispute over COVID-19 vaccine indemnity

 India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects
22-05-2021

Jaishankar may visit US next week; vaccine procurement on the agenda

 External Affairs Minister S Jaishankar is likely to visit the United States in the coming week, the visit is at the planning stage. There is no official announcement of the visit yet.India is engaged in talks with various US entities involved in Covid vaccines production and is looking forward to procuring and subsequently producing these vaccines.The issue of vaccine procurement is expected to be a key agenda item during Jaishankar's interaction with US leadership and other stakeholders.The US has already announced that it is going to distribute 80 million vaccines from its stockpile to countries in need.As India is struck badly by the second wave, so efforts of New Delhi will be to get maximum and also looking for tie-ups with vaccine developers to produce in India.US has a stockpile 60 million Astra Zeneca vaccine and also Pfizer, Moderna and Johnson & Johnson COVID-19 vaccines.US is playing a lead role in assisting India's fight against the COVID-19 virus. It has already...
21-05-2021
Next Page
Close

Let's Open Free Demat Account